Friday, April 30, 2010

Aging and oral health: effects in hard and soft tissues.

Curr Pharm Des. 2010;16(6):619-30.

Aging and oral health: effects in hard and soft tissues.

Department of Oral Sciences, University of Palermo, Italy.

Abstract

Changing demographics, including an increase in life expectancy and the growing numbers of elderly has recently focused attention on the need for geriatric dental care. Ageing affects oral tissues in addition to other parts of the human body, and oral health (including oral mucosa, lips, teeth and associated structures, and their functional activity) is an integral component of general health; indeed, oral disease can cause pain, difficulty in speaking, mastication, swallowing, maintaining a balanced diet, not to mention aesthetical considerations and facial alterations leading to anxiety and depression. The World Health Organization recommends the adoption of certain strategies for improving the oral health of the elderly, including the management and maintenance of oral conditions which are necessary for re-establishing effective masticatory function. Oral health is often neglected in the elderly, and oral diseases associated with aging are complex, adversely affecting the quality of life. Although oral health problems are not usually associated with death, oral cancers result in nearly 8,000 deaths each year, and more than half of these occur at an age of 65 years plus. This report, which is dedicated to geriatric physicians, geriatric dentistry and specialists in oral medicine reviews age-related oral changes in elderly patients and efforts to summarize the effects of aging in hard and soft oral tissues.

Thursday, April 29, 2010

FDA Approves Oravig (miconazole) Buccal Tablets for Treatment of Oropharyngeal Candidiasis

FDA Approves Oravig (miconazole) Buccal Tablets for Treatment of Oropharyngeal Candidiasis

Wednesday, April 28, 2010

ClearCorrect™ Makes its Exhibitor Debut and Presents its Invisible Aligner Alternative During American Association of Orthodontists Annual Session


ClearCorrect Makes its Exhibitor Debut and Presents its Invisible Aligner Alternative During American Association of Orthodontists Annual Session

Orthodontists Who Register as ClearCorrect Providers During the AAO Session
Will Receive Discounts on Workshop, Webinar, and Case Materials

Houston, TX – April 27, 2010 ClearCorrect, Inc., the clear alternative in advanced and affordable transparent orthodontic aligners, otherwise known as invisible braces, is making its exhibitor debut at the American Association of Orthodontists110th Annual Session in Washington, DC, May 1-4. The company will be presenting its clear aligner system at booth # 2654.

According to ClearCorrect founder and prominent cosmetic dentist Dr. Willis Pumphrey, "We’re very excited to be introducing the ClearCorrect transparent aligner system to members of the orthodontist community who may be looking for an affordable, clear alternative to braces without having to meet manufacturer-imposed annual CE requirements.”

While at the AAO Session, ClearCorrect will be running a special promotion whereby orthodontists who register to become ClearCorrect providers can attend a full-day, CE-accredited workshop normally priced at $995.00 for the reduced fee of $895.00. In addition, all workshop attendees will receive 50% off one ClearCorrect case of their choice.  

For newly-registered ClearCorrect providers unable to attend the hands-on workshop, training webinars may be a more convenient option. The regular webinar fee is $995.00, but has been reduced for AAO Session attendees to $895.00. What’s more, webinar participants will receive 50% off 2 ClearCorrect cases of their choice.

For updated workshop and webinar information, schedules, and registration, please call 1-888-331-3323, or visit http://www.clearcorrect.com/doctors/becomeaprovider.html.

“We want to make sure that orthodontists who register with ClearCorrect during the AAO Session are well trained and fully equipped to provide their patients with the most advanced and affordable clear braces available,” explained Dr. Pumphrey. “We hope that the live workshop and the webinar will accommodate as many of our new ClearCorrect providers as possible. We will schedule additional workshops and webinars if the demand warrants it.”
In the past year, thousands of dentists have made the invisible aligner switch to ClearCorrect. The reasons for making the switch include the following:

  • ClearCorrect was founded to make clear aligner therapy more affordable.

  • Lab fees are about 40% less than the competition.

  • Never had nor will have doctor proficiency requirements.

  • Doctors have increased control of patient treatment outcomes, as ClearCorrect aligners are delivered in phases (4 steps of treatment). This provides doctors the ability to make corrections as needed, without the additional cost to customize the results.

  • The ClearCorrect aligner system was developed by doctors for doctors. The company is focused on doctors’ needs and strives to continuously improve our service to our providers.  

  • ClearCorrect does not charge an additional fee for mid-course corrections or refinements.

  • Doctors receive the plastic models for each set of aligners so that they can fabricate replacement aligners in-house if needed, such as if the patient loses them.

  • Excellent customer service provided from Houston, Texas headquarters.

  • All ClearCorrect treatment products include retainers at no extra charge.

  • All products have compliance checkpoints or compliance indicators to ensure optimum results.

ClearCorrect’s exponential growth continues to be fueled by its focus on educating the profession, rather than the consumer, in an effort to build relationships with orthodontists and general dentists, who will in turn recommend the clinical and financial advantages of ClearCorrect to their patients. For more information on becoming a ClearCorrect provider, visit http://www.clearcorrect.com/doctors/becomeaprovider.html.

Tuesday, April 27, 2010

Single dose oral diflunisal for acute postoperative pain in adults.

Cochrane Database Syst Rev. 2010 Apr 14;4:CD007440.

Single dose oral diflunisal for acute postoperative pain in adults.

Magdalen College, University of Oxford, High Street, Oxford, Oxfordshire, UK, OX1 4AU.

Abstract

BACKGROUND: Diflunisal is a long-acting non-steroidal anti-inflammatory drug (NSAID) most commonly used to treat acute postoperative pain or chronic joint pain from osteoarthritis and rheumatoid arthritis. This review analyses the effectiveness and harm of different doses of diflunisal in the context of moderate to severe postoperative pain. OBJECTIVES: To assess efficacy, duration of action, and associated adverse events of single dose oral diflunisal in acute postoperative pain in adults. SEARCH STRATEGY: We searched Cochrane CENTRAL, MEDLINE, EMBASE and the Oxford Pain Relief Database for studies to January 2010. SELECTION CRITERIA: Randomised, double blind, placebo-controlled trials of single dose orally administered diflunisal in adults with moderate to severe acute postoperative pain. DATA COLLECTION AND ANALYSIS: Two review authors independently assessed trial quality and extracted data. Pain relief or pain intensity data were extracted and converted into the dichotomous outcome of number of participants with at least 50% pain relief over 4 to 6 hours, from which relative risk and number-needed-to-treat-to-benefit (NNT) were calculated. Numbers of participants using rescue medication over specified time periods, and time to use of rescue medication, were sought as additional measures of efficacy. Information on adverse events and withdrawals were collected. MAIN RESULTS: Nine studies in dental, orthopedic and gynaecological surgery met the inclusion criteria, testing doses of diflunisal from 125 mg to 1000 mg.For diflunisal 1000 mg, the NNT for at least 50% pain relief over 4 to 6 hours was 2.1 (1.8 to 2.6) (6 studies, 391 participants); the NNT to prevent remedication within 6 hours was 1.9 (1.7 to 2.3), and within 12 hours was 2.2 (1.9 to 2.7) (6 studies, 409 participants). More participants experienced adverse events with diflunisal 100 mg than with placebo, but none were serious or led to withdrawal.For diflunisal 500 mg, the NNT for at least 50% pain relief over 4 to 6 hours was 2.6 (2.1 to 3.3) (6 studies, 357 participants); the NNT to prevent remedication within 6 hours was 2.6 (2.1 to 3.4) (6 studies, 390 participants), and within 12 hours was 2.9 (2.3 to 4.0) (5 studies, 329 participants). Adverse events did not differ significantly from placebo. AUTHORS' CONCLUSIONS: Diflunisal has an analgesic effect similar to other NSAIDs in single dose, but benefits from providing significant analgesia for about twelve hours. This property may be useful when regular dosing is needed, or when taking several doses of a shorter acting analgesic is impractical.

Monday, April 26, 2010

Bacteraemia following dental implants' placement

Bacteraemia following dental implants' placement
Piñeiro A, Tomás I, Blanco J, Álvarez M, Seoane J, Diz P. Bacteraemia following dental implants' placement.
Clin. Oral Impl. Res. xx, 2010; 000–000.
doi: 10.1111/j.1600-0501.2010.01928.x

ABSTRACT

Objective: To investigate the prevalence, duration and aetiology of bacteraemias following the placement of implants as well as the prophylactic efficacy of a chlorhexidine digluconate (CHX) mouthrinse.
Material and methods: Fifty patients undergoing implant placement were randomly distributed into two groups:
Control group: 30 patients with no prophylactic intervention before surgery.
CHX group: 20 patients who performed a 0.2% CHX mouthrinse before surgery.
Blood samples were collected at baseline, at 30 s after the insertion of implants and at 15 min after completion of the suturing of the mucoperiosteal flap. Samples were processed in the Bactec 9240, and the subculture and further identification of the isolates were performed using conventional microbiological techniques.
Results: The prevalence of bacteraemias was 2% at baseline. In the control group, the prevalence of bacteraemias was 6.7% at 30 s and 3.3% at 15 min, but no statistically significant differences were achieved compared with the baseline percentage. In the CHX group, there were no positive cultures from blood samples obtained at 30 s or at 15 min.
Conclusions: Implant placement via a mucoperiosteal flap does not carry a significant risk of developing bacteraemias. The use of antibiotic prophylaxis for the prevention of focal infections such as bacterial endocarditis in "at-risk" patients undergoing dental implants is therefore questionable. Although its efficacy has not been confirmed statistically, we recommend a 0.2% CHX mouthrinse before treatment as proposed previously by the British Society for Antimicrobial Chemotherapy.

Saturday, April 24, 2010

20% of Lexi Online or On Hand subscriptions

20% of Lexi Online or On Hand subscriptions through the end April 30th. Use coupon code DNN410.  Go to the Lexi Web site. I use both version and they are great.

Friday, April 23, 2010

Invisalign Drops Case Minimum

This is from the Invisalign Web Site. Read the entire FAQ

We are responding to our customers’ frustration and unhappiness with the proficiency program. Many customers were upset by the proficiency program, particularly the annual case requirement. The volume of complaint letters has tapered off, but the mood and frustration of our customers has not improved.

In addition, numerous state and national dental organizations and their members oppose the case requirements. These are groups with whom we’ve always had good working relationships, and we don’t want to damage those relationships over this issue.

Many organizations, including the AAO and ADA, have recommended that Align focus on continuing education, rather than case requirements, as a means of encouraging product proficiency. We believe that these organizations will fully support this change regarding the annual case requirement.

Thursday, April 22, 2010

About MI Paste™ and MI Paste Plus™ It’s Like Vitamins for Your Teeth!

We use MI Paste Plus in my office for patients with white spot lesions and xerostomia. Its great for people in active orthodontic treatment. Check out the link to the MI paste commercial.

http://www.mi-paste.com/MI_Paste_Commercial.wmv

MI Paste is a one-of-a-kind product that restores minerals and helps you produce saliva. It is the only dental product with RECALDENT™ (CPP-ACP), a special milk-derived protein that is a breakthrough in oral health care in helping to remineralize teeth.
MI Paste and MI Paste Plus with RECALDENT (CPP-ACP):
• Strengthens your teeth with tooth-replenishing calcium and phosphate
• Releases vital minerals into your mouth when and where they are needed
• Produces a saliva-like environment that maintains normal acid levels and healthy teeth
• RECALDENT™ CPP-ACP is milk derived with lactose content less than 0.01%.*
• Helps condition, protect and rebuild your tooth surfaces
• Is a water-based, sugar-free crème that comes in five delicious flavors

Wednesday, April 21, 2010

What implant is that?

Lorne Lavine found this web site.


Have you ever found yourself staring at a new patient's radiograph puzzled, asking yourself the question, "What implant is that?"

whatimplantisthat.com is a free reference that is working to collect a comprehensive database of implant radiographs to assist dental practitioners in answering this question.

Here you will find a database of implant radiographs categorized by common characteristics. Is your implant threaded or non-threaded? Are there any holes in the apex? Through answering some of these simple questions, you can quickly filter out the radiographs you know are not what you're looking for, leaving you with similar radiographs to compare yours against. This is design to make implant radiographic identification easy and practical.

Tuesday, April 20, 2010

Backup Power For Your Portable Devices

Here in NJ we have had some very bad weather this year. During one such storm we lost power for more then a day. Besides losing heat and water I lost my cell phone service because my battery died. Luckily I could charge my phone in my car. So I decided I would get some backup power for my cell phone. I got one of these solar chargers. I can charge it from an electrical outlet, computer or the sun. It works well and have used it a few times while eating up my cell phone battery on the beach.  So think about ways to power your devices whether you have electrical power available or not. This device cost under $50 and comes with tips for many different cell phones and devices.

Monday, April 19, 2010

Selectively Etch with Confidence with 3M™ ESPE™ Adper™ Easy Bond Self-Etch Adhesive


                                      Free Samples are available on the Adper web page.                                                                                           

Selectively Etch with Confidence with

3M™ ESPE™ Adper™ Easy Bond Self-Etch Adhesive

Dentists can selectively etch or apply in one coat based on tooth being restored

ST. PAUL, Minn. – (April 13, 2010) – Evidence continues to mount in favor of 3M ESPE’s simple and convenient adhesive, 3M™ ESPE™ Adper™ Easy Bond Self-Etch Adhesive. An analysis shows that the product’s chemical properties make it uniquely suited for dentists who prefer to “selectively” etch when using self-etch adhesives. Additionally, new data reinforces the product’s effectiveness in delivering long-term bond strength* on both dentin and enamel. Its short application time allows it to be placed in 35 seconds, reducing the risk of contamination, and the product also offers virtually no post-operative sensitivity.** With Adper Easy Bond adhesive, dentists are one bottle away from a strong, reliable bond to dentin and enamel.
Research shows that Adper Easy Bond adhesive is compatible with the selective etch technique, which some dentists use with self-etch adhesives, and is typically recommended for 7th generation materials when uncut enamel is involved. With some self-etch adhesives, using a separate etchant on dentin can actually decrease the bond strength to dentin and affect margin quality.[i],[ii] However, studies demonstrate that with Adper Easy Bond adhesive, if the dentin is inadvertently etched during the selective enamel etching process, the dentin bond strength is not adversely affected, even if it is dried.
Additionally, the product helps dentists reach the common goal of minimizing post-operative sensitivity. A recent field evaluation of more than 5,000 restorations placed using Adper Easy Bond adhesive found that post-operative sensitivity was reported in less than 0.5% of cases.
Furthermore, because the product can be placed in 35 seconds, it reduces the risk of contamination versus adhesives with longer application times. The product is simply applied for 20 seconds, dried for 5 seconds and light-cured for 10 seconds.
This new research clearly demonstrates that whether dentists use Adper Easy Bond adhesive in its simple one-bottle, one-coat process, or selectively etch in addition to applying Adper Easy Bond adhesive, they can achieve consistent results.
For more information, visit www.3MESPE.com/Adper or call 1-800-634-2249.


[i] Van Landuyt K., Kanumilli P., De Munck J., Peumans M., Lambrechts P., Van Meerbeek B. Bond Strength of a Mild Self-Etch Adhesive With and Without Prior Acid-Etching

[ii] Ikeda M., Tsubota K., Takamizawa T., Yoshida T., Miyazaki M., Platt JA. Bonding Durability of Single-Step Adhesives to Previously Acid-Etched Dentin

Saturday, April 17, 2010

Aribex Settles Patent Infringement Case

I have 2 Nomads and my staff thinks they are the only way to shoot radiographs! MJ

Aribex Settles Patent Infringement Case

OREM, UTAH, USA ­April 13, 2010­ Aribex, Inc. announced today the settlement of a patent case involving Sigma Biomedics, Inc., Dentalaire Products International, and DigiMed Co., Ltd. The case was brought in the U.S. District Court for the District of Utah in October, 2009 alleging infringement of U.S. Patent No. 7,496,178 for a hand held x-ray device. None of the parties admitted any liability.

Under the terms of the settlement agreement, Sigma Biomedics, Dentalaire Products International and Digimed Co. have discontinued the distribution of the Bio-Ray PROX and similar hand-held x-ray devices within the United States. The other terms of the settlement agreement are confidential. Commenting on the settlement, Aribex President and CEO, Dr. Clark Turner, PhD, said. "We are pleased that the parties have chosen to resolve this matter amicably. We believe that this resolution is positive for Aribex, our customers, our partners, and the overall x-ray industry."

About Aribex
Aribex, Inc. is a privately held company headquartered in Orem, Utah. Aribex designs, develops and manufactures products in the x-ray radiography fields. Aribex's flagship products are NOMAD and NOMAD Pro handheld x-ray systems providing battery powered devices in dentistry and other x-ray imaging solutions in veterinary, medical, industrial, and security applications. For more information, please visit Aribex's web site: www.aribex.com.

Friday, April 16, 2010

Dentrix Mobile is Coming!

Be a part of the Dentrix Mobile beta program.

As a beta participant, you’ll be one of the first to use this exciting new software. You’ll also have the opportunity to tell us what you think, helping to guide the way for feature enhancements.
In order to participate in the Dentrix Mobile beta program you must be on an active Dentrix Customer Service Plan and have installed Productivity Pack 7.
Participating in the Dentrix Mobile beta program will require you to download new files and alter some of your current settings. By agreeing to participate, you are legally bound to comply with the terms of the Non-Disclosure Agreement. It is also your obligation to provide useful feedback about Dentrix Mobile during the beta process.

To sign up click here

Thursday, April 15, 2010

Exposure to dental amalgam restorations in pregnant women

Exposure to dental amalgam restorations in pregnant women
Gunvor Bentung Lygre   Lars Björkman , Kjell Haug, Rolv Skjærven  and Vigdis Helland 
Lygre GB, Björkman L, Haug K, Skjærven R, Helland V. Exposure to dental amalgam restorations in pregnant women. Community Dent Oral Epidemiol 2010. © 2010 John Wiley & Sons A/S

ABSTRACT

  Abstract – 
Objectives: The Norwegian Mother and Child Cohort Study (MoBa) started in 1999 to identify environmental factors that could be involved in mechanisms leading to disease. Questions have been raised about potential risks to the fetus from prenatal exposure to mercury from amalgam fillings in pregnant women. The aim of the present study was to identify factors potentially associated with amalgam fillings in pregnant women participating in the Norwegian Mother and Child Cohort Study (MoBa). An additional aim was to obtain information about dental treatment in the cohort.
Methods: Total of 67 355 pregnancies from the MoBa study were included in the present study. Information regarding age, education, smoking habits, alcohol consumption, weight, and height for the women was obtained from a questionnaire that was filled in at the 17th week of pregnancy. In another questionnaire, which was sent to all participants in the 30th week of pregnancy, the women reported types of dental treatment during pregnancy, total number of teeth, and number of teeth with amalgam fillings. The self-assessed number of teeth and number of teeth with amalgam fillings were validated in an external sample of 97 women of childbearing age.
Results: Odds ratio for having more than 12 teeth with amalgam fillings increased considerably with age. Other significant risk factors for having high exposure to amalgam were low education, high body mass index (BMI), and smoking during pregnancy. Women with the lowest levels of education had a twofold increased odds ratio of having more than 12 teeth filled with amalgam compared with women who had more than 4 years of university studies. According to the results from the validation of self-assessed number of teeth with amalgam fillings, the information obtained was reliable.
Conclusion: Age, education, smoking habits, and BMI were associated with amalgam exposure.

Wednesday, April 14, 2010

Clinical trials in zirconia: a systematic review

Journal of Oral Rehabilitation

Published Online: 9 Apr 2010

Clinical trials in zirconia: a systematic review
B. AL-AMLEH, K. LYONS & M. SWAIN

ABSTRACT

Summary Zirconia is unique in its polymorphic crystalline makeup, reported to be sensitive to manufacturing and handling processes, and there is debate about which processing method is least harmful to the final product. Currently, zirconia restorations are manufactured by either soft or hard-milling processes, with the manufacturer of each claiming advantages over the other. Chipping of the veneering porcelain is reported as a common problem and has been labelled as its main clinical setback. The objective of this systematic review is to report on the clinical success of zirconia-based restorations fabricated by both milling processes, in regard to framework fractures and veneering porcelain chipping. A comprehensive review of the literature was completed for in vivo trials on zirconia restorations in MEDLINE and PubMed between 1950 and 2009. A manual hand search of relevant dental journals was also completed. Seventeen clinical trials involving zirconia-based restorations were found, 13 were conducted on fixed partial dentures, two on single crowns and two on zirconia implant abutments, of which 11 were based on soft-milled zirconia and six on hard-milled zirconia. Chipping of the veneering porcelain was a common occurrence, and framework fracture was only observed in soft-milled zirconia. Based on the limited number of short-term in vivo studies, zirconia appears to be suitable for the fabrication of single crowns, and fixed partial dentures and implant abutments providing strict protocols during the manufacturing and delivery process are adhered to. Further long-term prospective studies are necessary to establish the best manufacturing process for zirconia-based restorations.

Tuesday, April 13, 2010

FDA: Pelton & Crane Pelton & Crane Spirit 3000 Dental Chair

 Class 3 Recall
Pelton & Crane Pelton & Crane Spirit 3000 Dental Chair
Date Posted April 09, 2010
Recall Number Z-1311-2010
Product Pelton & Crane Spirit 3000 Dental Chair. The intended use of this device is for properly positioning patients to perform dental procedures.
Code Information Catalog number: 3003, Model number: SP30, Chair Serial #14736
Recalling Firm/
Manufacturer
Pelton & Crane Company
11727 Fruehauf Dr
Charlotte, North Carolina 28273
Consumer Instructions Contact the recalling firm for information
For Additional Information Contact Mr. Frank Ray
704-588-2126 Ext. 227
Reason for
Recall
The Dental Chair lacks a valid Device History Record.
Action An "URGENT MEDICAL DEVICE RECALL" letter dated February 9, 2010, was delivered in person to the customer. The letter describe the product, problem and action to be taken by the customer. The customer was requested to provide the name and location of the consignee who received the chair so that Pelton & Crane can contact the end user to arrange to replace the affected chair with a new dental chair, and to complete the enclosed Recall Acknowledgement/Return Form and fax to (704) 587-7204. A monthly status report will be submitted to FDA. Please contact Pelton & Crane Customer Care at 1-800-659-6560 or call Mr. Frank Ray directly at 704-587-7227 to let us know where the device is currently stored.
Quantity in Commerce 1 unit
Distribution Nationwide distribution: NC

Monday, April 12, 2010

Palm is For Sale.

Looks like Palm is up for sale. What does this mean for Web OS, we will have to see.
http://www.bloomberg.com/apps/news?pid=newsarchive&sid=aVWvN6tilEFI

How ProDrive Handpieces Work


Here is a video describing how the ProDrive System of Turbines work in a conventional air drive handpiece to give you better control over the bur and more torque.

Sunday, April 11, 2010

STUDY CONCLUDES PULPDENT SEALANT HAS LONGER LASTING ANTIBACTERIAL ACTIVITY

STUDY CONCLUDES PULPDENT SEALANT HAS LONGER LASTING ANTIBACTERIAL ACTIVITY



WATERTOWN, MA:  April 8, 2010— A recent study published in the Journal of Dentistry concluded that Pulpdent Corporation’s Embrace™ Pit and Fissure Sealant had the longest lasting antibacterial activity of those studied.

The study, titled “Antibacterial surface properties of fluoride-containing resin-based sealants” was conducted at

The University of North Carolina at Chapel Hill School of Dentistry.



The aim of the study was to determine the antibacterial properties of three resin-based pit and fissure sealant products. The sealants were tested in both an agar diffusion assay and a planktonic growth inhibition assay using Streptococcus mutans and Lactobacillus acidophilus. Embrace retained antibacterial activity against both bacteria over time. While all the materials tested were capable of contact inhibition of L. acidophilus and S. mutans growth, the authors concluded that Embrace had the longer lasting antibacterial activity when in solution, especially against S. mutans.



Pulpdent manufactures high-quality products for the dental profession, including adhesives, composites, sealants, cements, etching gels, calcium hydroxide products, endodontic specialties and bonding accessories. For more information call 800-343-4342 or visit www.pulpdent.com

                          

Saturday, April 10, 2010

Willingness to pay for implant therapy: a study of patient preference

Willingness to pay for implant therapy: a study of patient preference
Katherine C. M. Leung  and Colman P. J. McGrath 
 

Clinical Oral Implants Research

Early View (Articles online in advance of print)

Published Online: 5 Apr 2010

ABSTRACT

Aims: This study determined the amount of willingness to pay (WTP) for implant treatment and identified the factors affecting WTP.
Methods: Subjects attending a university dental hospital were recruited (n=59). They were presented with two hypothetical clinical scenarios: missing one anterior/posterior tooth. The clinical procedures, outcome and plausible complications of various replacement options (fixed and removable partial dentures, implants) and sequelae of no treatment were presented. They were then asked how much they were willing to pay for tooth replacement under the two situations using a bidding method, with a starting bid of Hong Kong (HK)$20,000 in HK$1000 increment/decrement if they were willing/unwilling to pay that amount (1 USD=7.8 HKD). The amount was recorded at which the subject chose the opposite option or it reached HK$0. Demographic data were also collected. WTP values were compared between anterior and posterior replacements, and among various demographic subgroups. Spearman's correlations and linear regression analysis were also conducted.
Results: Ninety-four percent and 84% of the subjects chose implant treatment to replace missing anterior and posterior teeth, respectively. The mean WTP amounts for anterior/posterior tooth replacement were HK$11,000/HK$10,000 (P>0.05). Higher WTP amounts were obtained from females, subjects without missing teeth or restorative need, and had attained higher level of education (P<0.05). Gender (P<0.05), level of education (P=0.042), and the presence of missing teeth (P=0.001) were independent predictors of WTP.
Conclusions: The estimated WTP value for a single tooth replacement using dental implants was HK$10,000. Gender, level of education and presence of missing teeth were independent predictors that influenced WTP.

Friday, April 09, 2010

A New Minimal Invasive Dentistry Web Site

Dentalvillage is a new UK web site for information about Minimal Invasive Dentistry.  They are passionate about raising the profile of MID amongst the public and healthcare professions.

Go check it out
Dentalvillage

Thursday, April 08, 2010

Pulpdent announces Tuff Temp

WATERTOWN, MA:  March 26, 2010, 2010— Pulpdent Corporation has announced a Special Introductory Offer for Tuff-Temp™ Rubberized-Urethane™ Provisional System. During the introduction of Tuff-Temp Provisional Veneer, Crown & Bridge Resin, Pulpdent is including Tuff-Temp Provisional Glaze and Tuff-Temp Add-on flowable resin with all purchases as a free bonus special offer (a $45.00 value).

Tuff-Temp’s advanced rubberized-urethane chemistry provides greater strength and dimensional stability, and a tighter fitting provisional restoration, than acrylics and bis-acrylics. Breakage and debondings are minimized or eliminated. Tuff-Temp is also dual cure.

Tuff-Temp trims and powders to accurate margins and does not soften or distort during trimming and finishing. Finishing instruments do not gum up or clog. Tuff-Temp has the esthetics and handling of bis-acrylics and the strength of powder and liquid acrylics, but Tuff-Temp eliminates the brittleness, breakage, mixing, odor, heat generation, loose fit and debondings of acrylics and bis-acrylics.

A fast application of Tuff-Temp Provisional Glaze provides enhanced esthetics and patient satisfaction during temporization.

For alterations or smile design, the Tuff-Temp system includes Tuff-Temp Provisional Add-on, a shade-matching, light cure, flowable resin formulated from the Pulpdent’s proprietary rubberized-urethane chemistry.

Tuff-Temp both self-cures and has a light cure option to produce a full-strength restoration on demand. The fast light cure option is also ideal for use with a clear vinyl polysiloxane template.

Tuff-Temp is available in a 50 mL automix cartridge and 5 mL automix syringe and is offered in six popular shades: A1, A2, A3, A3.5, B1 and Bleach.

Pulpdent manufactures high-quality products for the dental profession, including adhesives, composites, sealants, cements, etching gels, calcium hydroxide products, endodontic specialties and bonding accessories. For more information call 800-343-4342 or visit www.pulpdent.com.  
                           
###

Wednesday, April 07, 2010

New Oral Mucositis Web Site

We use Caphosol in my office and I also offer free laser treatment for any cancer patient with mucositis whether a patient in my practice or not. MJ


Mouths Made Good

We are excited to share with you a new patient educational website that was recently launched to help patients with oral mucositis. Our goal was to provide a useful and informative resource where people can learn about this painful condition, share their insights, and help others overcome this lesser known side effect of cancer treatment.

The new site provides detailed information about the following:

    * The condition itself - what are the symptoms and how long will they last
    * The type of patients at risk - who is more likely to get oral mucositis
    * The consequences of oral mucositis
    * Oral mucositis management strategies
    * Diet and nutrition tips, and much more!

We invite you to visit www.mouthsmadegood.com and we hope that you will find it useful when you educate your patients on the condition and treatment options.

The Caphosol® Team
(Supersaturated Calcium Phosphate Rinse)

Caphosol Safety Information:

    * If Caphosol is swallowed accidently, no adverse effects are expected
    * There are no known interactions with other medications
    * Reported side effects have been rare and generally mild



Tuesday, April 06, 2010

The latest issue of Apex


We are pleased to present you with the latest monthly issue of APEX in digital turning-page format.

Click the following link to open the latest issue:

To watch my video editorial click here

Read in this issue  

Watch video interview with Chris Barrow here
"What is your most important question about attracting new patients?" Chris Barrow in Expert advice at your figertips read more about the Ask Coach Barrow campaign on page

    * "Many dental laboratories find photography useful for understanding the anatomical features of a patient, seeing the textures and natural reflections from existing teeth and colour and shade matching." Mike Samuels in Documenting through a lens on page
    * "The higher the energy, the greater the practice performance. That’s why successful dentists don’t try to justify or defend making money.” Dr Marc Cooper in Polar opposites: service vs profitability on page
    * Technology highlights from the Chicago Midwinter exhibition floor by Dr Marty Jablow
    * Latest jobs in dentistry on page 

We hope you enjoy APEX and take the opportunity to forward it or recommend it to your colleagues and peers. 

If you haven't already, please join our tribe on Facebook www.theapextribe.com


Best wishes!



Marita Kritzinger
Editorial Director
APEX

Saturday, April 03, 2010

Surefil SDR flow

There are new composites all the time coming to market and most of the time we all say composite is composite. Besides the self-etch composites here is something new from Dentsply Caulk. The first true bulk fill composite. You can add up to 4mm increments and light cure.

For more information check out the SureFil SDR web site.

To read the Dental Advisor Review

Friday, April 02, 2010

NobelProcera manufacturing facility to be featured on the television program "How It's Made"

News Alert
NobelProcera™ manufacturing facility to be featured on the television program “How It’s Made”

Nobel Biocare is pleased to announce that their state-of-the-art CAD/CAM dental manufacturing facility has been chosen to be featured in an upcoming episode of How It’s Made. The segment was filmed at the company’s Mahwah, NJ facility and will focus on how a dental crown is designed and then individually manufactured.

How It’s Made is an international program produced by Productions Maj in Quebec, Canada. The show airs in more than 180 countries and focuses on the manufacturing process of many items such as airplanes, fiber optics, even toothpicks. The show has been on the air since 2001.

The segment on dental crowns is one of four topics that will be featured on this 30-minute season premiere on April 2, 2010 at 9 p.m. EST on the Science Channel.

Check your local listings for the Science Channel in your area. If you have satellite TV you can view the program on DirectTV Channel 284 and Dish Network Channel 193.


Thursday, April 01, 2010

OSAP launches new website

Annapolis, MD:  March 29, 2010 - The Organization for Safety & Asepsis Procedures (OSAP) has launched a new website at www.osap.org. The OSAP website is the gateway for accessing up-to-the-minute research-based information on infection control and safety in dentistry.  The site features charts, checklists, training tools, continuing education programs, news summaries, and more. Much of the content is available to the public, but OSAP members are able to access special content and features. 

A new social networking capability allows OSAP members to connect with each other, as well as follow the organization on Facebook and Twitter, view photos and videos on Flickr and YouTube, and subscribe to the RSS feed. A Safety Mall offers products and services relating to infection control and includes downloadable materials, for those with an immediate need. The new site features a fresh look and many new features.


Special content is available for speakers, consultants, dental professionals, and others concerned about infection control and safety in dentistry. Visitors can also get information and register for events, such as the 2010 Infection Prevention Symposium, which will be held June 10-13, 2010 at the Hyatt Regency in Tampa, Florida.

The OSAP website is updated on at least a daily basis, but when pandemics, natural disasters, or other breaking developments that impact infection control occur, the site is updated multiple times a day.  Visit www.osap.org frequently to stay current on fast-changing safety and infection control challenges.


OSAP is the Organization for Safety and Asepsis Procedures.  Founded in 1984, the non-profit association is dentistry's premier resource for infection control and safety information.  Through its publications, courses, website, and worldwide collaborations, OSAP and the tax-exempt OSAP Foundation support education, research, service, and policy development to promote safety and the control of infectious diseases in dental healthcare settings worldwide.